Caprock Group, Inc. Grifols Sa Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$16.28 - $25.63 $146,389 - $230,464	-8,992 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$19.57 - $23.52 $175,973 - $211,491	8,992 New	8,992 $209,000
Q2 2018 Jul 23, 2018	SELL	$20.16 - $24.68 $191,842 - $234,854	-9,516 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$20.31 - $24.95 $193,269 - $237,424	9,516 New	9,516 $202,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.